PPD (PPD) Days Sales Outstanding : 60.22 (As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is PPD Days Sales Outstanding?

PPD's average Accounts Receivable for the three months ended in Sep. 2021 was $1,030 Mil. PPD's Revenue for the three months ended in Sep. 2021 was $1,561 Mil. Hence, PPD's Days Sales Outstanding for the three months ended in Sep. 2021 was 60.22.

The historical rank and industry rank for PPD's Days Sales Outstanding or its related term are showing as below:

PPD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.83 Med: 63.62 Max: 71.36
Current: 55.83

During the past 5 years, PPD's highest Days Sales Outstanding was 71.36. The lowest was 55.83. And the median was 63.62.

PPD's Days Sales Outstanding is not ranked
in the Drug Manufacturers industry.
Industry Median: 72.57 vs PPD: 55.83

PPD's Days Sales Outstanding increased from Sep. 2020 (53.84) to Sep. 2021 (60.22).

PPD Days Sales Outstanding Historical Data

The historical data trend for PPD's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PPD Days Sales Outstanding Chart

PPD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Days Sales Outstanding

71.36

62.65

64.58

56.98

PPD Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Days Sales Outstanding	Get a 7-Day Free Trial									53.84	51.11	54.39	56.08	60.22

Competitive Comparison of PPD's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, PPD's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PPD's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PPD's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PPD's Days Sales Outstanding falls into.

PPD Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PPD's Days Sales Outstanding for the fiscal year that ended in Dec. 2020 is calculated as

	Days Sales Outstanding (A: Dec. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2019 )	+	Accounts Receivable (A: Dec. 2020 ))	/	count )	/	Revenue (A: Dec. 2020 )	*	Days in Period
=	( (726.111	+	735.568)	/	2 )	/	4681.474	*	365
=	730.8395					/	4681.474	*	365
=	56.98

PPD's Days Sales Outstanding for the quarter that ended in Sep. 2021 is calculated as:

	Days Sales Outstanding (Q: Sep. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2021 )	+	Accounts Receivable (A: Sep. 2021 ))	/	count )	/	Revenue (A: Sep. 2021 )	*	Days in Period
=	( (1028.954	+	1031.077)	/	2 )	/	1560.796	*	365 / 4
=	1030.0155					/	1560.796	*	365 / 4
=	60.22

PPD (NAS:PPD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

PPD Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PPD's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

PPD (PPD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PPD Inc (NAS:PPD) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

929 North Front Street, Wilmington, NC, USA, 28401

Website

https://www.ppdi.com

PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.

Executives

H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
H&f Corporate Investors Vii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
David Michael Johnston	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
David S Simmons	director, officer: Chief Executive Officer	PFIZER INC. ATTN. CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Glen Donovan	officer: Chief Accounting Officer	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Ronald E Garrow	officer: See Remarks	2000 PURCHASE STREET, PURCHASE NY 10577
Karen Kaucic	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Judd Hartman	officer: See Remarks	3124 DEVER COURT WILMINGTON NC 28411
Jill Pellegrino	officer: SVP & General Manager of AES	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
H&f Executives Vii, L.p.	10 percent owner	ONE MARITIME PLAZA 12TH FLOOR SAN FRANCISCO CA 94111
Hellman & Friedman Investors Viii, L.p.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
P. Hunter Philbrick	director	C/O HELLMAN & FRIEDMAN INVESTORS, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Carlyle Partners Vi Holdings Ii, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Tc Group Vi, L.l.c.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA ANVENE, N.W., WASHINGTON DC 20004
Tc Group Vi, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004